{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:33Z","timestamp":1792788033814,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Foundation of China","award":["82403748"],"award-info":[{"award-number":["82403748"]}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1293"],"award-info":[{"award-number":["2024NSFSC1293"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Research Projects of Qinghai Provincial Department of Science and Technology","award":["2023-ZJ-791"],"award-info":[{"award-number":["2023-ZJ-791"]}],"id":[{"id":"https:\/\/ror.org\/03vz7b375","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08552-w","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:26:39Z","timestamp":1783995999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal immune-inflammation mapping of the GERD-Barrett-adenocarcinoma cascade identifies FGF19-HLA-DR\u207a T-cell axis driving esophagogastric junction metaplasia"],"prefix":"10.1186","volume":"24","author":[{"given":"Yixin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"8552_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/cncr.27834","volume":"119","author":"C Hur","year":"2013","unstructured":"Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119:1149\u201358.","journal-title":"Cancer"},{"key":"8552_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00535-019-01593-7","volume":"54","author":"KEL McColl","year":"2019","unstructured":"McColl KEL. What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East? J Gastroenterol. 2019;54:669\u201373.","journal-title":"J Gastroenterol"},{"key":"8552_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1542-3565(05)00248-X","volume":"3","author":"RC Fitzgerald","year":"2005","unstructured":"Fitzgerald RC. Complex diseases in gastroenterology and hepatology: GERD, Barrett\u2019s, and esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3:529\u201337.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8552_CR4","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1001\/jama.2020.21360","volume":"324","author":"J Maret-Ouda","year":"2020","unstructured":"Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA. 2020;324:2536\u201347.","journal-title":"JAMA"},{"key":"8552_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.it.2015.06.007","volume":"36","author":"S Fichtner-Feigl","year":"2015","unstructured":"Fichtner-Feigl S, Kesselring R, Strober W. Chronic inflammation and the development of malignancy in the GI tract. Trends Immunol. 2015;36:451\u20139.","journal-title":"Trends Immunol"},{"key":"8552_CR6","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1053\/j.gastro.2015.07.010","volume":"149","author":"BJ Reid","year":"2015","unstructured":"Reid BJ, Paulson TG, Li X. Genetic Insights in Barrett\u2019s Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2015;149:1142\u2013e11521143.","journal-title":"Gastroenterology"},{"key":"8552_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00535-017-1342-1","volume":"52","author":"RF Souza","year":"2017","unstructured":"Souza RF. Reflux esophagitis and its role in the pathogenesis of Barrett\u2019s metaplasia. J Gastroenterol. 2017;52:767\u201376.","journal-title":"J Gastroenterol"},{"key":"8552_CR8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jcmgh.2022.01.023","volume":"13","author":"L Tambunting","year":"2022","unstructured":"Tambunting L, Kelleher D, Duggan SP. The Immune Underpinnings of Barrett\u2019s-Associated Adenocarcinogenesis: a Retrial of Nefarious Immunologic Co-Conspirators. Cell Mol Gastroenterol Hepatol. 2022;13:1297\u2013315.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"8552_CR9","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ"},{"key":"8552_CR10","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.ajhg.2025.06.001","volume":"112","author":"A Ray","year":"2025","unstructured":"Ray A, Alabarse P, Malik R, Sargurupremraj M, Bernhagen J, Dichgans M, Baumeister SE, Georgakis MK. Single-cell transcriptome-wide Mendelian randomization and colocalization analyses uncover cell-specific mechanisms in atherosclerotic cardiovascular disease. Am J Hum Genet. 2025;112:1597\u2013609.","journal-title":"Am J Hum Genet"},{"key":"8552_CR11","doi-asserted-by":"publisher","first-page":"105341","DOI":"10.1016\/j.ebiom.2024.105341","volume":"108","author":"SE Wang","year":"2024","unstructured":"Wang SE, Viallon V, Lee M, Dimou N, Hamilton F, Biessy C, O\u2019Mara T, Kyrgiou M, Crosbie EJ, Truong T, et al. Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses. EBioMedicine. 2024;108:105341.","journal-title":"EBioMedicine"},{"key":"8552_CR12","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman \u00c5K, Kalnapenkis A, Enroth S, Cozzetto D, Digby-Bell J, Marten J, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24:1540\u201351.","journal-title":"Nat Immunol"},{"key":"8552_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036\u201345.","journal-title":"Nat Genet"},{"key":"8552_CR14","doi-asserted-by":"publisher","first-page":"eadj1182","DOI":"10.1126\/science.adj1182","volume":"385","author":"A Verma","year":"2024","unstructured":"Verma A, Huffman JE, Rodriguez A, Conery M, Liu M, Ho YL, Kim Y, Heise DA, Guare L, Panickan VA, et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science. 2024;385:eadj1182.","journal-title":"Science"},{"key":"8552_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/gutjnl-2021-326698","volume":"72","author":"J Schr\u00f6der","year":"2023","unstructured":"Schr\u00f6der J, Chegwidden L, Maj C, Gehlen J, Speller J, B\u00f6hmer AC, Borisov O, Hess T, Kreuser N, Venerito M, et al. GWAS meta-analysis of 16 790 patients with Barrett\u2019s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level. Gut. 2023;72:612\u201323.","journal-title":"Gut"},{"key":"8552_CR16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S1470-2045(16)30240-6","volume":"17","author":"P Gharahkhani","year":"2016","unstructured":"Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, et al. Genome-wide association studies in oesophageal adenocarcinoma and Barrett\u2019s oesophagus: a large-scale meta-analysis. Lancet Oncol. 2016;17:1363\u201373.","journal-title":"Lancet Oncol"},{"key":"8552_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s43556-025-00285-4","volume":"6","author":"J Zhou","year":"2025","unstructured":"Zhou J, Zhao R, Li Z, Ma X, Jin W, Yuan Y, Li N, Liu B, Yang Y. LncRNA small nucleolar RNA host gene 1 (SNHG1) mediates acidic bile salt-induced EMT via the ULK1-Notch1 axis in Barrett\u2019s esophagus. Mol Biomed. 2025;6:49.","journal-title":"Mol Biomed"},{"key":"8552_CR18","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1158\/1078-0432.CCR-17-1756","volume":"24","author":"HY Fang","year":"2018","unstructured":"Fang HY, M\u00fcnch NS, Schottelius M, Ingermann J, Liu H, Schauer M, Stangl S, Multhoff G, Steiger K, Gerngro\u00df C, et al. CXCR4 Is a Potential Target for Diagnostic PET\/CT Imaging in Barrett\u2019s Dysplasia and Esophageal Adenocarcinoma. Clin Cancer Res. 2018;24:1048\u201361.","journal-title":"Clin Cancer Res"},{"key":"8552_CR19","doi-asserted-by":"crossref","unstructured":"Lagisetty KH, McEwen DP, Nancarrow DJ, Schiebel JG, Ferrer-Torres D, Ray D, Frankel TL, Lin J, Chang AC, Kresty LA, Beer DG. Immune determinants of Barrett\u2019s progression to esophageal adenocarcinoma. JCI Insight. 2021;6.","DOI":"10.1172\/jci.insight.143888"},{"key":"8552_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaci.2023.07.008","volume":"153","author":"TH Nguyen","year":"2024","unstructured":"Nguyen TH, Kumar D, Prince C, Martini D, Grunwell JR, Lawrence T, Whitely T, Chappelle K, Chonat S, Prahalad S, et al. Frequency of HLA-DR(+)CD38(hi) T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders. J Allergy Clin Immunol. 2024;153:309\u201319.","journal-title":"J Allergy Clin Immunol"},{"key":"8552_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1053\/j.gastro.2024.01.020","volume":"166","author":"Z Li","year":"2024","unstructured":"Li Z, Yang K. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett\u2019s Esophagus: Insights from a Mendelian Randomization Study. Gastroenterology. 2024;166:944\u20135.","journal-title":"Gastroenterology"},{"key":"8552_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2018.06.038","volume":"155","author":"A Al-Khaifi","year":"2018","unstructured":"Al-Khaifi A, Rudling M, Angelin B. An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers. Gastroenterology. 2018;155:1012\u20136.","journal-title":"Gastroenterology"},{"key":"8552_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1053\/j.gastro.2017.07.007","volume":"153","author":"G Contino","year":"2017","unstructured":"Contino G, Vaughan TL, Whiteman D, Fitzgerald RC. The Evolving Genomic Landscape of Barrett\u2019s Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2017;153:657\u2013e673651.","journal-title":"Gastroenterology"},{"key":"8552_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/joim.13767","volume":"295","author":"X Li","year":"2024","unstructured":"Li X, Lu W, Kharitonenkov A, Luo Y. Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. J Intern Med. 2024;295:292\u2013312.","journal-title":"J Intern Med"},{"key":"8552_CR25","doi-asserted-by":"publisher","first-page":"633453","DOI":"10.3389\/fphar.2021.633453","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang C, Li J, Zhu J, Zhao C, Xu H. Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer. Front Pharmacol. 2021;12:633453.","journal-title":"Front Pharmacol"},{"key":"8552_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","volume":"79","author":"M Xie","year":"2023","unstructured":"Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, Chen X, Zhang B, Liang H, Liu D, et al. FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. J Hepatol. 2023;79:109\u201325.","journal-title":"J Hepatol"},{"key":"8552_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fcell.2020.00095","volume":"8","author":"Y Liu","year":"2020","unstructured":"Liu Y, Cao M, Cai Y, Li X, Zhao C, Cui R. Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression. Front Cell Dev Biol. 2020;8:95.","journal-title":"Front Cell Dev Biol"},{"key":"8552_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7150\/thno.121601","volume":"16","author":"J Xu","year":"2026","unstructured":"Xu J, Sun P, Zhu W, Liu X, Ma L. FGF19 in Solid Tumors: Molecular Mechanisms, Metabolic Reprogramming, and Emerging Therapeutic Opportunities. Theranostics. 2026;16:345\u201397.","journal-title":"Theranostics"},{"key":"8552_CR29","doi-asserted-by":"crossref","unstructured":"Chia L, Wang B, Kim JH, Luo LZ, Shuai S, Herrera I, Chen SY, Li L, Xian L, Huso T, et al. HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation. J Clin Invest. 2023;133.","DOI":"10.1172\/JCI151601"},{"key":"8552_CR30","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1158\/2159-8290.CD-19-0555","volume":"9","author":"RD Kim","year":"2019","unstructured":"Kim RD, Sarker D, Meyer T, Yau T, Macarulla T, Park JW, Choo SP, Hollebecque A, Sung MW, Lim HY, et al. First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma. Cancer Discov. 2019;9:1696\u2013707.","journal-title":"Cancer Discov"},{"key":"8552_CR31","doi-asserted-by":"publisher","first-page":"eadw1702","DOI":"10.1126\/sciadv.adw1702","volume":"11","author":"H Guo","year":"2025","unstructured":"Guo H, Wang B, Wu Z, Zhang Q, Jiang X, Zhang F, Zhou J, Fan S, Zhou Y, Xu ZL, et al. CD8(+)HLA-DR(+)CD27(+) T cells define a population of naturally occurring regulatory precursors in humans. Sci Adv. 2025;11:eadw1702.","journal-title":"Sci Adv"},{"key":"8552_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/jcp.48.6.539","volume":"48","author":"JC Rockett","year":"1995","unstructured":"Rockett JC, Darnton SJ, Crocker J, Matthews HR, Morris AG. Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. J Clin Pathol. 1995;48:539\u201344.","journal-title":"J Clin Pathol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08552-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:02:56Z","timestamp":1791468176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08552-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8552"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08552-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental protocols were approved by the Ethics Committee of West China Hospital, Sichuan University (Approval number: No.20220107005). All animal experiments were in accordance with the guide for the care and use of laboratory animals established by the United States National Institutes of Health.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not include details, images, or videos relating to an individual person; therefore, consent for publication is not needed beyond the informed consent provided by all study participants as described above.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1268"}}